secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLARIVATE PLC (CLVT)
CIK:        0001764046
Form:       8-K
Filed at:   2026-07-06T10:01:11+00:00
Accession:  0001764046-26-000085
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clarivate sells Life Sciences & Healthcare segment to Altaris for $600M
-----------------------------------------------------------------------

- Deal value $600M: $500M cash at close, $25M deferred cash, $75M seller note.
- Proceeds to reduce debt; transaction expected to close by end of 2026.
- Reaffirms FY2026 outlook; LS&H to be classified as discontinued ops from Q3.
- Expects non-cash goodwill impairment of $225-250M on LS&H segment.
- Company sharpens focus on Academia & Government and Intellectual Property segments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/0001764046-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/clvt-20260706.htm
  HTML page:      https://secwatch.observer/filing/0001764046-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer